Skip to main content
. 2019 Feb 21;64(5):E180–E188.

Table II.

Patient Image for Each Hoehn & Yahr Stage

N=252

Yahr stage 1 Yahr stage 2 Yahr stage 3 Yahr stage 4 Yahr stage 5

n average±SD n average±SD n average±SD n average±SD n average±SD
age PD 16 71.5±4.9 31 70.5±6.3 96 72.4±6.6 63 74.5±6.0 22 78.9±6.9
YOPD 1 81.0±0.0 3 63.0±7.9 10 61.9±10.6 6 59.0±10.5 4 59.5±10.7

Disease Duration (Years) PD 16 6.0±3.3 31 7.7±4.4 93 11.1±6.0 62 15.5±11.6 22 19.1±13.8
YOPD 1 16.0±0.0 3 10.3±4.0 10 21.7±8.7 6 19.0±3.9 4 14.3±2.2

Number of Types of Medicines (for PD) PD 16 2.4±1.1 30 3.1±1.5 90 4.2±1.7 59 4.8±2.5 21 4.0±2.7
YOPD 1 2.0±0.0 3 7.7±5.0 9 6.0±3.4 5 6.0±4.2 4 4.8±2.8

Number of Days to Next Appointment PD 16 42.1±14.0 29 55.1±24.7 94 48.6±22.1 61 46.2±24.2 17 55.1±27.3
YOPD 1 30.0±0.0 3 27.0±5.2 10 40.6±29.7 6 38.0±22.5 2 60.0±42.4

(breakdown, %) (breakdown, %) (breakdown, %) (breakdown, %) (breakdown, %)

People with motor fluctuation PD 16 2 (12.5%) 31 9 (29.0%) 96 43 (44.8%) 63 32 (50.8%) 22 10 (45.5%)
YOPD 1 0 (0.0%) 3 1 (33.3%) 10 6 (60.0%) 6 5 (83.3%) 4 3 (75.0%)

Off Time Per Day (Only People with motor fluctuation) PD 5 2.4±0.9 12 3.6±1.4 51 4.1±3.1 39 4.4±3.2 9 5.0±2.4
YOPD 0 - 2 8.0±2.8 6 3.8±2.0 4 6.3±5.9 1 20.0±0.0
HHS Vulnerability Disclosure